Michael Schmidt Upgraded (AGIO) to Buy on, Aug 2nd, 2017
Michael Schmidt of Leerink Swann, Upgraded "Agios Pharmaceuticals, Inc." (AGIO) to Buy on, Aug 2nd, 2017.
Michael has made no other calls on AGIO in the last 4 months.
There is 1 other peer that has a rating on AGIO. Out of the 1 peers that are also analyzing AGIO, all agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Debjit Chattopadhyay of "Janney Montgomery Scott" Downgraded from Strong Buy to Hold on, Monday, June 26th, 2017